Literature DB >> 34820686

Psychiatric comorbidity in the Baltimore ECA follow-up study: the matrix approach.

Ruben Miozzo1,2,3,4, William Eaton5,6, O Joseph Bienvenu5,7,6, Jack Samuels5,6, Gerald Nestadt5,6.   

Abstract

BACKGROUND: Psychiatric comorbidity is defined as the joint occurrence of two or more mental or substance use disorders. Widespread psychiatric comorbidity has been reported in treatment and population-based studies. The aim of this study was to measure the extent and impact of psychiatric comorbidity in a cohort of the Baltimore Epidemiologic Catchment Area study.
METHODS: We examined the comorbidity burden of 16 mental disorders in a cohort of 847 participants using both established and novel analytical approaches The Comorbidity to Diagnosis Inflation Ratio (CDIR), is a statistical instrument that quantifies impact of pairwise comorbid associations, both on the whole sample, as well as on each specific disorder.
RESULTS: Most anxiety disorders had substantial co-occurrence with each other, as well as with Major Depressive Disorder (MDD). In addition, mood disorders had a high degree of comorbidity with Alcohol Dependence (AD). The CDIR for the whole sample was 1.32, indicating a ratio of 132 comorbidities per 100 diagnoses. The conditions with high sample prevalence were relatively less comorbid than the low prevalence conditions. Obsessive Compulsive Disorder had a comorbidity burden that was 89% greater than the overall sample.
CONCLUSION: Anxiety disorders are highly interrelated, as well as highly comorbid with depression. The comorbidity phenomenon is linked to the differential prevalence of the analyzed conditions. Comorbidity frequency (most prevalent comorbid condition) appears mutually exclusive to comorbidity burden (most widely interrelated condition). While AD and MDD were the most frequently diagnosed disorders; low prevalence conditions as OCD and GAD were the most widely interrelated.
© 2021. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany.

Entities:  

Keywords:  Measurement; Psychiatric comorbidity

Year:  2021        PMID: 34820686     DOI: 10.1007/s00127-021-02184-9

Source DB:  PubMed          Journal:  Soc Psychiatry Psychiatr Epidemiol        ISSN: 0933-7954            Impact factor:   4.328


  2 in total

1.  Bipolar disorder, schizoaffective disorder, and schizophrenia overlap: a new comorbidity index.

Authors:  Thomas Munk Laursen; Esben Agerbo; Carsten Bøcker Pedersen
Journal:  J Clin Psychiatry       Date:  2009-06-16       Impact factor: 4.384

2.  Comorbidities in the diseasome are more apparent than real: What Bayesian filtering reveals about the comorbidities of depression.

Authors:  Peter Marx; Peter Antal; Bence Bolgar; Gyorgy Bagdy; Bill Deakin; Gabriella Juhasz
Journal:  PLoS Comput Biol       Date:  2017-06-23       Impact factor: 4.475

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.